Cargando…

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

PURPOSE: Oral agents are needed that improve glycemic control without increasing hypoglycemic events in patients with type 1 diabetes (T1D). Sotagliflozin may meet this need, because this compound lowers blood glucose through the insulin-independent mechanisms of inhibiting kidney SGLT2 and intestin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Powell, David R, Doree, Deon, Jeter-Jones, Sabrina, Ding, Zhi-Ming, Zambrowicz, Brian, Sands, Arthur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346285/ https://www.ncbi.nlm.nih.gov/pubmed/25759591 http://dx.doi.org/10.2147/DMSO.S76342

Ejemplares similares

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
por: Sands, Arthur T., et al.
Publicado: (2015)

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption
por: Powell, David R, et al.
Publicado: (2019)

OR22-5 Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption
por: Powell, David, et al.
Publicado: (2019)

A review of sotagliflozin for use in type 1 diabetes
por: Nuffer, Wesley, et al.
Publicado: (2019)

Androgen treatment prevents diabetes in nonobese diabetic mice
Publicado: (1992)

Breaking self-tolerance in nonobese diabetic mice
Publicado: (1996)

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
por: Itoh, Naoto, et al.
Publicado: (1997)

Spontaneous Autoimmune Diabetes in Monoclonal T Cell Nonobese Diabetic Mice
por: Verdaguer, Joan, et al.
Publicado: (1997)

I-E+ nonobese diabetic mice develop insulitis and diabetes
Publicado: (1993)

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
por: van Raalte, Daniël H., et al.
Publicado: (2019)

Diacylglycerol Lipase α Knockout Mice Demonstrate Metabolic and Behavioral Phenotypes Similar to Those of Cannabinoid Receptor 1 Knockout Mice
por: Powell, David R., et al.
Publicado: (2015)

The Role of Macrophages in T Cell–mediated Autoimmune Diabetes in Nonobese Diabetic Mice
por: Jun, Hee-Sook, et al.
Publicado: (1999)

Reduced Incidence and Delayed Onset of Diabetes in Perforin-deficient Nonobese Diabetic Mice
por: Kägi, David, et al.
Publicado: (1997)

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study
por: Posch, Maximilian G., et al.
Publicado: (2022)

Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides
Publicado: (1995)

A Critical Role for Lymphotoxin-β Receptor in the Development of Diabetes in Nonobese Diabetic Mice
por: Ettinger, Rachel, et al.
Publicado: (2001)

Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women
por: Zaman, Gaffar Sarwar, et al.
Publicado: (2015)

A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice
por: Grohmann, Ursula, et al.
Publicado: (2003)

Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction
por: Kim, Inho, et al.
Publicado: (2023)

Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A protocol for Systematic review and Meta-analysis
por: Chen, Mao-Bing, et al.
Publicado: (2019)

A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52 : A protocol for mixed treatment comparisons meta-analysis
por: Zhang, Nie, et al.
Publicado: (2019)

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
Publicado: (1993)

Cd1-Restricted Nk T Cells Protect Nonobese Diabetic Mice from Developing Diabetes
por: Wang, Bin, et al.
Publicado: (2001)

Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
Publicado: (1996)

Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic Mice
por: Parker, Matthew J., et al.
Publicado: (2009)

Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse
Publicado: (1987)

High-Throughput Screening of Mouse Gene Knockouts Identifies Established and Novel High Body Fat Phenotypes
por: Powell, David R, et al.
Publicado: (2021)

Reversal of Spontaneous Autoimmune Insulitis in Nonobese Diabetic Mice by Soluble Lymphotoxin Receptor
por: Wu, Qiang, et al.
Publicado: (2001)

NOTUM inhibition increases endocortical bone formation and bone strength
por: Brommage, Robert, et al.
Publicado: (2019)

LP-925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2
por: Powell, David R, et al.
Publicado: (2015)

Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A systematic review and meta-analysis
por: Chen, Mao-Bing, et al.
Publicado: (2020)

The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials
por: Zhou, Feifei, et al.
Publicado: (2022)

The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
por: Ansari, Mohammed Javeed I., et al.
Publicado: (2003)

The journey from gene knockout to clinical medicine: telotristat and sotagliflozin
por: Rendell, Marc S
Publicado: (2019)

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
por: Cefalo, Chiara Maria Assunta, et al.
Publicado: (2019)

Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023)

Nonobese, Nonketotic Childhood-Onset Diabetes: Look for Lipodystrophies
por: Chakraborty, Partha P., et al.
Publicado: (2017)

Metabolomic Profiles of Nonobese and Obese Women With Gestational Diabetes
por: Sormunen-Harju, Heidi, et al.
Publicado: (2023)

Radioiodinated Naphthylalanine Derivatives Targeting Pancreatic Beta Cells in Normal and Nonobese Diabetic Mice
por: Amartey, John K., et al.
Publicado: (2008)

Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice
por: Tanca, Alessandro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gkl9rqvqtd3tpv9n7qirl2kik5